Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Prostate Cancer Clinical Trials in Florida | 681 Studies

Clinical Trials Prostate CancerFlorida

Prostate Cancer Clinical Trials in Florida

Find 681 clinical trials for prostate cancer near Florida. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Florida

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 121-140 of 681 trials

CompletedA Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)The purpose of this study is to determine if newly diagnosed (within previous 3 months) participants with metastatic (spread of cancer cells from one part of the body to another )…NCT01715285·Buenos Aires and 207 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsThe purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors.NCT06533059·La Jolla, California and 30 others

Active not recruitingMarker Driven Selection of Patients for Prostate Biopsy and ManagementThe purpose of this research study is to determine if the interpretation of multiparametric MRI (mpMRI) with an algorithm called habitat risk score (HRS) in combination with a…NCT04240327·Miami, Florida

RecruitingA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerThe main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.NCT06879041·Palo Alto, California and 15 others

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

CompletedThalidomide for the Treatment of Hormone-Dependent Prostate CancerThis multi-center study will evaluate whether thalidomide can improve the effectiveness of the drugs leuprolide or goserelin in treating testosterone-dependent prostate cancer.NCT00004635·Fort Lauderdale, Florida and 8 others

CompletedA Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate CancerA phase I, randomized, open-label and active-control study to assess the PK, PD and safety profiles of LY01005 versus goserelin comparator to be conducted in the USA.NCT03450109·Anniston, Alabama and 4 others

RecruitingA Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid TumorsThis is a Phase 1b, 2-part, multi-center, open-label study to evaluate the safety, tolerability, dosimetry, and pharmacokinetics (PK) of \[64Cu\]Cu-AKY-2519 and/or…NCT07887971·Miami, Florida and 1 other

Active not recruitingContinued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsThis extended clinical investigation is a multicenter, prospective, single arm study intended to provide continued access of the Exablate Model 2100 device (Exablate Prostate) to…NCT03998657·Stanford, California and 4 others

Active not recruitingAn Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to compare the radiographic progression-free survival (rPFS) of apalutamide in combination with abiraterone acetate (AA) plus prednisone or…NCT02257736·Phoenix, Arizona and 172 others

Active not recruitingA Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsThis study is a first-in-human (FIH), Phase 1a/1b study of BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), to assess the safety, tolerability, pharmacokinetics (PK)…NCT06257264·Newport Beach, California and 23 others

CompletedThe AIM Study: Assessing the Impact of Margin ReductionThis study will observe patients who receive external beam radiation for prostate cancer.NCT00754000·Scottsdale, Arizona and 3 others

CompletedEpoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate CancerRATIONALE: Epoetin alfa may stimulate red blood cell production and may help improve cancer-related anemia and fatigue.NCT00060398·Modesto, California and 139 others

CompletedZoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesRATIONALE: Zoledronate may prevent or decrease skeletal (bone)-related events (such as pain or fractures) caused by bone metastases and androgen deprivation therapy.NCT00079001·Mobile, Alabama and 240 others

CompletedSatraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy RegimenPURPOSE: The SPARC trial is designed to compare the combination of the investigational oral cytotoxic drug, satraplatin, and prednisone, versus prednisone alone as second line…NCT00069745·Birmingham, Alabama and 210 others

CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersThis is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in…NCT03454451·Tucson, Arizona and 26 others

CompletedA Study of Leuprolide to Treat Prostate CancerTo assess the efficacy and safety of 2 new formulations of leuprolide acetate 45 mg 6-month depot, Formulation A or Formulation B, for the treatment of patients with prostate…NCT00626431·Birmingham, Alabama and 62 others

CompletedA Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane RegimenThis Phase III, multicenter, randomized, open-label study will evaluate the safety and efficacy of atezolizumab (anti-programmed death-ligand 1 \[anti-PD-L1\] antibody) in…NCT03016312·Duarte, California and 157 others

TerminatedKZR-261 in Subjects With Advanced Solid MalignanciesA first-in-human, open-label, multicenter, Phase 1 study of KZR-261 designed to assess the safety and tolerability, preliminary anti-tumor activity, and pharmacokinetics (PK) of…NCT05047536·Los Angeles, California and 11 others

CompletedA Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to evaluate the serum testosterone levels in patients with Metastatic Castration-Resistant Prostate Cancer on SoluMatrix™ Abiraterone Acetate as…NCT02737332·Laguna Hills, California and 16 others

PreviousPage 7 of 35Next

Other Conditions in Florida

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma